"Sylvester Comprehensive Cancer Center is the only university-based comprehensive cancer center and only NCI-designated cancer center in the region. With more treatment options and more clinical trials than most hospitals in the southeastern United States, Sylvester is advancing cancer care in the region and beyond — all in pursuit of your cure. Teams of physicians and scientists work together to move discoveries from Sylvester's labs to patients and out into the community. As the home to South Florida's only Phase 1 Clinical Trials program, Sylvester offers novel treatments and hope to patients with rare forms of cancer."

During the past decade, Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" are "Multiple Myeloma" (1 trials) and "Neoplasms" (1 trials). Many other conditions were trialed in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" in a lesser frequency.

Most popular intervention types in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "Capecitabine" (1 trials), "Cetuximab" (1 trials) and "Elranatamab + Nirogacestat" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sylvester Comprehensive Cancer Center- The Lennar Foundation Medical Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".